Home » Healthcare » Rare Disease Treatment Market

Rare Disease Treatment Market By Pharmaceuticals and Biologics (Orphan Drugs, Biological Therapies); By Gene Therapies (Gene Replacement Therapies, Gene Editing Technologies); By Enzyme Replacement Therapies (ERT) (Lysosomal Storage Disorders); By Small Molecule Therapies (Chaperone Therapies, Modulators of Disease Pathways); By Stem Cell Therapies (Hematopoietic Stem Cell Transplantation (HSCT, Mesenchymal Stem Cell Therapy); By Rare Cancer Therapies (Targeted Therapies, Immunotherapies); By Diagnostic and Monitoring Tools (Genetic Testing, Biomarker Testing); By Supportive Therapies (Palliative Care, Symptomatic Treatments); By Rare Cancer Therapies (Hospitals and Clinics, Specialty Treatment Centers, Home Healthcare); By Collaborations and Partnerships (Academic and Industry Collaborations); By Region – Growth, Share, Opportunities & Competitive Analysis, 2023 – 2030

Price: $4999

Published: | Report ID: 32473 | Report Format : PDF

Market Insights

  • The global demand for Rare Disease Treatment was valued at USD 192455.5 million in 2022 and is expected to reach USD 493799.3 Million in 2030, growing at a CAGR of 12.50% between 2023 and 2030.
  • The biological therapeutics category is projected to be dominant in the rare illness treatment market.
  • The most prominent section is gene replacement therapy, and gene editing technologies such as CRISPR-Cas9 have garnered significant attention and potential.
  • Lysosomal storage disorders (LSDs) constitute a substantial market segment in the Rare Disease Treatment Market.
  • Chaperone Therapies is the most rapidly expanding segment of the Rare Disease Treatment Market.
  • The market’s most important category is hematopoietic stem cell transplantation (HSCT).
  • The market’s most important category is hematopoietic stem cell transplantation (HSCT).
  • Genetic testing has traditionally seen rising market demand, and biomarker testing is another key market area.
  • Palliative Care is the fastest growing market segment, with Symptomatic Treatments following closely behind.
  • Another big market area is symptomatic treatments, and another important market segment is specialty treatment centres.
  • Academic and industry collaborations  account for a sizable portion of the rare disease therapeutic market.
  • With a revenue share of more than 60.0% in 2022, North America has emerged as the main player in the rare illness treatment industry, and Asia Pacific is expected to expand at the fastest rate.
  • The increasing prevalence of rare diseases promotes market expansion.
  • Market expansion is hampered by high costs in compared to alternative technologies.

Rare Disease Treatment Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

The Rare Disease Treatment Market refers to the market for drugs, treatments, and interventions created and utilized to treat rare diseases. Rare diseases are medical problems that afflict a small fraction of the population. Because of their rarity and the difficulties involved in studying and developing medicines for them, many diseases frequently have limited therapeutic options. The Rare Disease Treatment Market focuses on meeting the unmet medical requirements of patients with rare diseases by delivering customized treatments and therapies to improve their quality of life. Pharmaceutical corporations, biotechnology firms, research institutions, and healthcare providers all collaborate to develop and deliver breakthrough treatments for uncommon diseases.

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Rare Disease Treatment Market will expand at a compound annual growth rate (CAGR) of 12.50%. From USD 192455.5million in 2022, the market is projected to be worth USD 493799.3 million by 2030.

The Rare Disease Treatment Market is a subset of the healthcare business focused on developing and delivering medicines for rare diseases. Rare diseases are medical problems that affect a tiny number of people. Because of their rarity and the difficulties connected with researching and developing medicines for them, many diseases frequently have limited therapeutic options.

In recent years, the market for rare disease medicines has grown as a result of advances in medical research, increased awareness of rare diseases, and legislative incentives to stimulate development in this area. Pharmaceutical businesses, biotechnology companies, and research organizations all play critical roles in creating novel cures and drugs for uncommon diseases.

The market is characterized by a high level of unmet medical requirements, as many rare diseases lack viable therapies. This creates chances for companies to develop novel therapies and drugs to meet these unmet requirements. However, the market faces constraints like as expensive research and development costs, limited patient populations, and complex regulatory pathways.

Segmentation by Pharmaceuticals and Biologics

  • Biological therapies are treatments that use living organisms or compounds produced from them, such as cells, DNA, or antibodies, to cure rare diseases. This segment is considered dominating in the rare illness treatment market because biological treatments have shown promising outcomes in targeting specific disease pathways and providing effective therapy alternatives for patients. These medicines can be adjusted to individual patients depending on their genetic composition, resulting in more personalized and focused treatments.

Segmentation by Gene Therapies

  • Gene replacement therapies are the most prominent section of the Rare Disease Treatment Market. Gene replacement therapies include inserting functioning genes into the cells of a patient to replace or complement the faulty ones that cause the rare disease. This method seeks to deliver a functional copy of the gene while also restoring normal cellular function.
  • While gene editing technologies such as CRISPR-Cas9 have attracted substantial attention and potential, they are still in their early phases of development and confront major obstacles in terms of efficacy, safety, and ethical considerations.

Segmentation by Enzyme Replacement Therapies (ERT)

  • Lysosomal storage disorders (LSDs) represent a significant market category in the Rare Disease Treatment Market. LSDs are a set of inherited metabolic illnesses caused by a lack of particular enzymes in the lysosomes, which are in charge of breaking down various compounds in the body. As a result, undegraded chemicals accumulate within the lysosomes, causing cellular malfunction and damage in many organs.

Segmentation by Small Molecule Therapies

  • Chaperone Therapies is the fastest-growing area of the Rare Disease Treatment Market. Chaperone Therapies involve the use of tiny molecules or chemical compounds in the body to help stabilize and improve the function of misfolded or unstable proteins. These treatments try to increase protein function and restore correct protein folding, which can be disturbed in some uncommon disorders. They have demonstrated potential in the treatment of diseases such as cystic fibrosis and lysosomal storage disorders.

Segmentation by Stem Cell Therapies

  • Hematopoietic Stem Cell Transplantation (HSCT) is the important segment in the market. Hematopoietic Stem Cell Transplantation (HSCT) is the transplantation of stem cells taken from bone marrow, peripheral blood, or umbilical cord blood. It is often used to treat a variety of rare diseases, including specific kinds of leukemia, lymphoma, and genetic disorders. HSCT seeks to replace or restore the patient’s damaged or malfunctioning blood-forming cells with healthy ones.
  • On the other hand, Mesenchymal Stem Cell Therapy  focuses on the utilization of mesenchymal stem cells (MSCs) obtained from bone marrow, adipose tissue, or umbilical cord tissue. These stem cells have the ability to develop into diverse cell types, as well as influence the immune response and promote tissue repair.

Segmentation by Rare Cancer Therapies

  • Immunotherapies have grown in popularity in the market. Immunotherapies are treatments that use the immune system’s power to combat diseases, including certain types of cancer. They function by stimulating or boosting the body’s natural defences, allowing aberrant cells to be recognized and destroyed more effectively.
  • On the other hand, Targeted therapies are treatments that directly target certain molecules or processes implicated in illness development and progression.

Segmentation by Diagnostic and Monitoring Tools

  • Genetic testing has typically witnessed increased market demand. Genetic testing aids in the identification of certain genetic mutations or variations that may be linked to rare diseases. It aids in the diagnosis of rare diseases, the prediction of disease development, and the direction of treatment decisions.
  • On the other hand, Biomarker testing entails the examination of specific molecules or signs in the body that can provide information about a disease or its course.

Segmentation by Supportive Therapies

  • Palliative Care is the fastest expanding market segment. Palliative care aims to improve the quality of life for those suffering from serious illnesses, particularly uncommon diseases, by controlling symptoms, giving emotional support, and addressing patients’ and their families’ general well-being.
  • Symptomatic Treatments is another significant market sector.

Segmentation by End-User

  • Hospitals and clinics have the biggest market share. Hospitals and clinics offer a wide range of medical services, including uncommon disease diagnosis, treatment, and management. They have the necessary infrastructure, medical skills, and resources to meet the complicated demands of people suffering from uncommon diseases.
  • Specialty Treatment Centres are another key market category. These facilities are devoted to a single rare disease or a group of linked rare diseases.

Segmentation by Collaborations and Partnerships

  • Academic and industry collaborations represent a significant sector of the market for rare disease therapy. Partnerships between academic institutions (such as universities and research centres) and industrial organizations (such as pharmaceutical companies and biotech firms) are common in these collaborations.

Segmentation by Region

  • North America has emerged as the dominant player in the rare illness treatment sector, with a revenue share of more than 60.0% in 2022.
  • Asia Pacific is predicted to expand the fastest growth rate.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Rare Disease Treatment.

Rare Disease Treatment Market Research

North America has emerged as the major player in the rare illness treatment industry, with a dominating revenue share of more than 60.0% in 2022. This is due to a number of variables, including the high prevalence of rare diseases, a strong healthcare infrastructure, and the consistent approval of novel therapeutic solutions. Tezepelumab, designed for the treatment of eosinophilic esophagitis (EoE), received orphan drug classification from the US FDA in October 2021, marking a key milestone for AstraZeneca. The availability of treatment alternatives might contribute to increased patient compliance, hence extending the consumer base and driving revenue growth in the industry.

In addition, during the projection period, the Asia Pacific region is expected to grow the fastest. This tendency is impacted by governments’ aggressive attempts to provide assistance to those affected by orphan illnesses. For instance, the Indian government urged national and state organizations to actively implement health policies geared at the care of patients with orphan illnesses in July 2022. Such government initiatives present a substantial opportunity for producers to supply high-quality orphan pharmaceuticals to the government, thereby generating cash. This geographical forecast highlights the potential for significant growth in the rare disease treatment market.

Key Highlights of the Report

The global Rare Disease Treatment Market is segmented by Pharmaceuticals and Biologics, Gene Therapies,  Enzyme Replacement Therapies (ERT), Small Molecule Therapies, Stem Cell Therapies, Rare Cancer Therapies and region. Chaperone Therapies is the fastest-growing section of the Rare Disease Treatment Market, with Hematopoietic Stem Cell Transplantation (HSCT) being the most important. Furthermore, immunotherapies have grown in popularity in the industry, and genetic testing has seen an increase in market demand. Also, hospitals and clinics have the largest market share, with Asia Pacific leading the market growth.

The primary drivers of the industry are increased government support and regulatory incentives, advances in genomic medicine and precision medicines, and increased awareness and advocacy for rare diseases. Furthermore, the primary market barriers are limited patient populations and fragmented markets for rare illnesses, high costs associated with research and development, and complex regulatory pathways and obstacles.

Nonetheless, With a revenue share of more than 60.0% in 2022, North America has emerged as the dominant player in the rare illness treatment sector. Furthermore, the Asia Pacific area is predicted to develop the quickest during the projection period.

 What Elements Are Driving the Global Market for Rare Disease Treatment?

The increased government support and regulatory incentives for rare illness research and development are significant factors in the Rare illness Treatment Market. Governments all over the world recognize the importance of addressing rare diseases and are giving funds and incentives to encourage corporations to invest in R&D activities. Furthermore, advances in genetic medicine and precision medicines have been propelling the industry. Understanding the genetic and molecular basis of these illnesses enables focused therapy for rare diseases. Furthermore, rising awareness and support for rare diseases have resulted in greater financing and research collaborations, moving the industry forward even further.

What Are The Main Obstacles That The Global Rare Disease Treatment Market Faces?

While the Rare Disease Treatment Market offers promise, there are still obstacles to overcome. The small patient populations and fragmented markets associated with rare diseases are substantial impediments. Because these illnesses are uncommon, the number of patients afflicted is tiny, making it difficult to obtain economies of scale. This can lead to increased prices and a smaller market for companies developing medicines for uncommon diseases. Furthermore, the high expenses of research and development, clinical trials, and manufacturing of rare disease medicines are a substantial impediment. The complexity of these diseases, as well as the necessity for specialist therapies, contribute to the high expenses.

What Market Development Prospects Are There For Rare Disease Treatment Globally?

Despite the challenges, the Rare Disease Treatment Market offers numerous potential for growth and innovation. The growth of orphan drug development programs is one such opportunity. Orphan drug designations provide firms developing medicines for uncommon diseases with financial incentives and regulatory support. This increases investment in R&D initiatives, which leads to the creation of more effective medicines. Furthermore, the industry will benefit from the deployment of novel technologies such as gene treatments and gene editing. By directly targeting the underlying genetic causes of many illnesses, these cutting-edge technologies have the potential to transform rare disease therapy.

Market Drivers

The global Rare Disease Treatment Market is driven by several factors. The following are the key drivers of the global Rare Disease Treatment Market:

Rare Diseases Are Becoming More Common

According to the US Food and Drug Administration, a rare disease affects less than 200,000 people in the US, and according to the Cheisi Global Rare Disease article in 2022, the burden of rare diseases is approximately 10x higher than the burden of mass market diseases per patient per year (PPPY). Furthermore, according to the European Commission Public Health, the disease affected no more than one person in the European Union in 2000. Rare diseases afflict less than five people in every 10,000 in Canada. Similarly, according to the February 2022 update of rarediseaseday.org, approximately 300 million individuals are living with rare diseases, which is a large number.

As a result of the high burden and increased awareness, the demand for effective and improved treatment solutions for rare diseases is expected to rise. This is projected to drive expansion in the market under consideration throughout the forecast period. The utilization of diverse distribution channels for rare illness therapy, such as internet pharmacies, specialty pharmacies, and hospital pharmacies, has resulted in increased demand for rare disease treatment.

Furthermore, factors such as an increase in the number of rare illness cases and immunization campaigns, combined with novel treatments and medications, as well as an increase in the number of new drug launches and favorable government policies, are driving overall market growth.

Market Restraints

The global Rare Disease Treatment Market faces some challenges that may hinder its growth. These include the following:

High Expenses In Comparison To Other Technologies

Even though the advanced sequencing sector is rapidly increasing, there are a few critical issues that must be addressed in order to enable future growth. The comparatively high total costs of delivering sequencing test results in compared to other technology platforms, as well as payers’ limited coverage, are the key barriers to the expansion of this industry. Whole genome and exome sequencing remain very expensive because they require an initial investment in technology, specialist personnel, and a large amount of time to examine variants.

Opportunities

The global Rare Disease Treatment Market offers significant growth opportunities. These include the following:

Increasing Number Of Drug Approvals

According to Pharmaceutical Research and Manufacturers of America, there will be approximately 791 potential orphan rare disease medication candidates in clinical trials by 2021. There were 168 clinical orphan medications for rare cancers, 120 for rare blood cancers, 56 for neurological disorders, 192 for genetic disorders, 54 for blood disorders, 51 for autoimmune diseases, and 36 for infectious diseases among all clinical orphan drugs. In 2021, the Centre for Drug Evaluation and Research (CDER) approved around 26 innovative orphan medicines for the treatment of uncommon diseases. Amondys 4, Bylvay, Welireg, Lumakras, Scemblix, Welireg, Cytalux, Besremi, Empaveli, Evkeeza, Exkivity, fexinidazole, and Zynlonta were among the authorized products. As a result, increased rare illness drug approval and the introduction of novel orphan pharmaceuticals are expected to drive market growth.

Competitive Landscape

Rare Disease Treatment Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global Rare Disease Treatment Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • F. Hoffmann-La Roche Ltd.
  • Pfizer, Inc.
  • PTC Therapeutics
  • AstraZeneca
  • Novartis AG
  • Novo Nordisk
  • Bayer AG
  • AbbVie Inc.
  • Merck & Co. Inc.
  • Bristol Myers Squibb
  • BayerAG

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Rare Disease Treatment Market’s key players continually seek to stay ahead by offering new Pharmaceuticals and Biologicss and developments.

In January 2023, Novartis stated that sebelipase alfa has been approved for the treatment of patients with lipoprotein lipase deficiency (LPLD). Sebelipase alfa is a gene therapy that replaces the missing or faulty lipoprotein lipase enzyme.

In March 2023, Bimekizumab has been approved by Pfizer for the treatment of atopic dermatitis. Bimekizumab is a biologic that is intended to inhibit the activity of the cytokines IL-17A and IL-17F, which are involved in the inflammation associated with atopic dermatitis.

Summary of Key Findings

  • The rising number of medicinal approvals will propel the rare disease treatment market forward.
  • Market segmented by Pharmaceuticals and Biologics, Gene Therapies,  Enzyme Replacement Therapies (ERT), Small Molecule Therapies, Stem Cell Therapies, Rare Cancer Therapies and region
  • Hematopoietic Stem Cell Transplantation (HSCT) is the most important market sector.
  • Lysosomal storage disorders (LSDs) are a prominent market segment in the Rare Disease Treatment Market.
  • North America is leading market growth; the market is highly competitive with key players including F. Hoffmann-La Roche Ltd.; Pfizer, Inc.; PTC Therapeutics; AstraZeneca.

Future Outlook

  • Growing investment in rare illness research and development
  • Advances in genetic and molecular diagnostics
  • Expansion of orphan medication development programs
  • Raising awareness and advocacy for rare diseases
  • Industry, academic, and patient organizations working together
  • Adoption of novel technology for rare illness diagnosis and treatment
  • Continued regulatory support and incentives

Segmentation

  • By Pharmaceuticals and Biologics:
    • Orphan Drugs
    • Biological Therapies
  • By Gene Therapies:
    • Gene Replacement Therapies
    • Gene Editing Technologies
  • By Enzyme Replacement Therapies (ERT):
    • Lysosomal Storage Disorders
  • By Small Molecule Therapies:
    • Chaperone Therapies
    • Modulators of Disease Pathways
  • By Stem Cell Therapies:
    • Hematopoietic Stem Cell Transplantation (HSCT)
    • Mesenchymal Stem Cell Therapy
  • By Rare Cancer Therapies:
    • Targeted Therapies
    • Immunotherapies
  • By Diagnostic and Monitoring Tools:
    • Genetic Testing
    • Biomarker Testing
  • By Supportive Therapies:
    • Palliative Care
    • Symptomatic Treatments
  • By Rare Cancer Therapies:
    • Hospitals and Clinics
    • Specialty Treatment Centers
    • Home Healthcare
  • By Collaborations and Partnerships:
    • Academic and Industry Collaborations
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Rare Disease Treatment Market
2.1.1. Global Rare Disease Treatment Market, By Pharmaceuticals and Biologics
2.1.2. Global Rare Disease Treatment Market, By Gene Therapies
2.1.3. Global Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT)
2.1.4. Global Rare Disease Treatment Market, By Small Molecule Therapies
2.1.5. Global Rare Disease Treatment Market, By Stem Cell Therapies
2.1.6. Global Rare Disease Treatment Market, By Rare Cancer Therapies
2.1.7. Global Rare Disease Treatment Market, By Diagnostic and Monitoring Tools
2.1.8. Global Rare Disease Treatment Market, By Supportive Therapies
2.1.9. Global Rare Disease Treatment Market, By End-User
2.1.10. Global Rare Disease Treatment Market, By Collaborations and Partnerships
2.1.11. Global Rare Disease Treatment Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Rare Disease Treatment Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Rare Disease Treatment Market Drivers
3.2.2. Rare Disease Treatment Market Restraints
3.2.3. Rare Disease Treatment Market Opportunities
3.2.4. Major Rare Disease Treatment Market Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Pharmaceuticals and Biologics
3.5.2. Gene Therapies
3.5.3. Enzyme Replacement Therapies (ERT)
3.5.4. Small Molecule Therapies
3.5.5. Stem Cell Therapies
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Rare Disease Treatment Market: Company Market Share, Value 2022
4.1.2. Global Rare Disease Treatment Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Rare Disease Treatment Market: Top 3 Company Market Share, Value 2022
4.2. Global Rare Disease Treatment Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type Matrix
4.7. Potential for New Players in the Global Rare Disease Treatment Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Engineering Immune Cells in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Rare Disease Treatment Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type Mix
7.2.4. Reduced Engineering Immune Cells Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Rare Disease Treatment Market, By Pharmaceuticals and Biologics
8.1. Global Rare Disease Treatment Market Overview, By Pharmaceuticals and Biologics
8.1.1. Global Rare Disease Treatment Market Revenue Share, By Pharmaceuticals and Biologics, 2022 Vs 2030 (in %)
8.2. Orphan Drugs
8.2.1. Global Rare Disease Treatment Market, By ORPHAN DRUGS, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for ORPHAN DRUGS
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Biological Therapies
8.3.1. Global Rare Disease Treatment Market, By Biological Therapies, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Biological Therapies
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global Rare Disease Treatment Market, By Gene Therapies
9.1. Global Rare Disease Treatment Market Overview, By Gene Therapies
9.1.1. Global Rare Disease Treatment Market Revenue Share, By Gene Therapies, 2022 Vs 2030 (in %)
9.2. Gene Replacement Therapies
9.2.1. Global Rare Disease Treatment Market, By Gene Replacement Therapies, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Gene Replacement Therapies
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Gene Editing Technologies
9.3.1. Global Rare Disease Treatment Market, By Gene Editing Technologies, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Gene Editing Technologies
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT)
10.1. Global Rare Disease Treatment Market Overview, By Enzyme Replacement Therapies (ERT)
10.1.1. Global Rare Disease Treatment Market Revenue Share, By Enzyme Replacement Therapies (ERT), 2022 Vs 2030 (in %)
10.2. For Lysosomal Storage Disorders
10.2.1. Global Rare Disease Treatment Market, By For Lysosomal Storage Disorders, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for For Lysosomal Storage Disorders
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
11. Global Rare Disease Treatment Market, By Small Molecule Therapies
11.1. Global Rare Disease Treatment Market Overview, by Small Molecule Therapies
11.1.1. Global Rare Disease Treatment Market Revenue Share, By Small Molecule Therapies, 2022 Vs 2030 (in %)
11.2. Chaperone Therapies
11.2.1. Global Rare Disease Treatment Market, By Chaperone Therapies, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Chaperone Therapies
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Modulators of Disease Pathways
11.3.1. Global Rare Disease Treatment Market, By Modulators of Disease Pathways, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Modulators of Disease Pathways
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global Rare Disease Treatment Market, By Stem Cell Therapies
12.1. Global Rare Disease Treatment Market Overview, By Stem Cell Therapies
12.1.1. Global Rare Disease Treatment Market Revenue Share, By Stem Cell Therapies, 2022 Vs 2030 (in %)
12.2. Hematopoietic Stem Cell Transplantation (HSCT)
12.2.1. Global Rare Disease Treatment Market, By Hematopoietic Stem Cell Transplantation (HSCT), By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Hematopoietic Stem Cell Transplantation (HSCT)
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Mesenchymal Stem Cell Therapy
12.3.1. Global Rare Disease Treatment Market, By Mesenchymal Stem Cell Therapy, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Mesenchymal Stem Cell Therapy
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global Rare Disease Treatment Market, By Rare Cancer Therapies
13.1. Global Rare Disease Treatment Market Overview, By Rare Cancer Therapies
13.1.1. Global Rare Disease Treatment Market Revenue Share, By Rare Cancer Therapies, 2022 Vs 2030 (in %)
13.2. Targeted Therapies
13.2.1. Global Rare Disease Treatment Market, By Targeted Therapies, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Targeted Therapies
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Immunotherapies
13.3.1. Global Rare Disease Treatment Market, By Immunotherapies, By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Immunotherapies
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. Global Rare Disease Treatment Market, By Diagnostic and Monitoring Tools
14.1. Global Rare Disease Treatment Market Overview, By Diagnostic and Monitoring Tools
14.1.1. Global Rare Disease Treatment Market Revenue Share, By Diagnostic and Monitoring Tools, 2022 Vs 2030 (in %)
14.2. Genetic Testing
14.2.1. Global Rare Disease Treatment Market, By Genetic Testing, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Genetic Testing
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Biomarker Testing
14.3.1. Global Rare Disease Treatment Market, By Biomarker Testing, By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for Biomarker Testing
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
15. Global Rare Disease Treatment Market, By Supportive Therapies
15.1. Global Rare Disease Treatment Market Overview, By Supportive Therapies
15.1.1. Global Rare Disease Treatment Market Revenue Share, By Supportive Therapies, 2022 Vs 2030 (in %)
15.2. Palliative Care
15.2.1. Global Rare Disease Treatment Market, By Palliative Care, By Region, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for Palliative Care
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Symptomatic Treatments
15.3.1. Global Rare Disease Treatment Market, By Symptomatic Treatments, By Region, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Symptomatic Treatments
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. Global Rare Disease Treatment Market, By End-User
16.1. Global Rare Disease Treatment Market Overview, By End-User
16.1.1. Global Rare Disease Treatment Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
16.2. Hospitals and Clinics
16.2.1. Global Rare Disease Treatment Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for Hospitals and Clinics
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. Specialty Treatment Centers
16.3.1. Global Rare Disease Treatment Market, By Specialty Treatment Centers, By Region, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for Specialty Treatment Centers
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends
16.4. Home Healthcare
16.4.1. Global Rare Disease Treatment Market, By Home Healthcare, By Region, 2017-2030 (US$ Mn)
16.4.2. Market Dynamics for Home Healthcare
16.4.2.1. Drivers
16.4.2.2. Restraints
16.4.2.3. Opportunities
16.4.2.4. Trends
17. Global Rare Disease Treatment Market, By Collaborations and Partnerships
17.1. Global Rare Disease Treatment Market Overview, By Collaborations and Partnerships
17.1.1. Global Rare Disease Treatment Market Revenue Share, By Collaborations and Partnerships, 2022 Vs 2030 (in %)
17.2. Academic and Industry Collaborations
17.2.1. Global Rare Disease Treatment Market, By Academic and Industry Collaborations, By Region, 2017-2030 (US$ Mn)
17.2.2. Market Dynamics for Academic and Industry Collaborations
17.2.2.1. Drivers
17.2.2.2. Restraints
17.2.2.3. Opportunities
17.2.2.4. Trends
18. Global Rare Disease Treatment Market, By Region
18.1. Global Rare Disease Treatment Market Overview, by Region
18.1.1. Global Rare Disease Treatment Market, By Region, 2022 vs 2030 (in%)
18.2. Pharmaceuticals and Biologics
18.2.1. Global Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030 (US$ Mn)
18.3. Gene Therapies
18.3.1. Global Rare Disease Treatment Market, By Gene Therapies, 2017-2030 (US$ Mn)
18.4. Enzyme Replacement Therapies (ERT)
18.4.1. Global Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030 (US$ Mn)
18.5. Small Molecule Therapies
18.5.1. Global Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030 (US$ Mn)
18.6. Stem Cell Therapies
18.6.1. Global Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030 (US$ Mn)
18.7. Rare Cancer Therapies
18.7.1. Global Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030 (US$ Mn)
18.8. Diagnostic and Monitoring Tools
18.8.1. Global Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030 (US$ Mn)
18.9. Supportive Therapies
18.9.1. Global Rare Disease Treatment Market, By Supportive Therapies, 2017-2030 (US$ Mn)
18.10. End-User
18.10.1. Global Rare Disease Treatment Market, By End-User, 2017-2030 (US$ Mn)
18.11. Collaborations and Partnerships
18.11.1. Global Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030 (US$ Mn)
19. North America Rare Disease Treatment Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. North America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. North America Rare Disease Treatment Market, By Gene Therapies, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. North America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. North America Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. North America Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. North America Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. North America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. North America Rare Disease Treatment Market, By Supportive Therapies, 2017-2030(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. North America Rare Disease Treatment Market, By End-User, 2017-2030(US$ Mn)
19.10.1. Overview
19.10.2. SRC Analysis
19.11. North America Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030(US$ Mn)
19.11.1. Overview
19.11.2. SRC Analysis
19.12. North America Rare Disease Treatment Market, by Country, 2017-2030(US$ Mn)
19.12.1. North America Rare Disease Treatment Market, by Country, 2022 Vs 2030 (in%)
19.12.2. U.S.
19.12.3. Canada
19.12.4. Mexico
20. Europe Rare Disease Treatment Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Europe Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Europe Rare Disease Treatment Market, By Gene Therapies, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Europe Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Europe Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Europe Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Europe Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Europe Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Europe Rare Disease Treatment Market, By Supportive Therapies, 2017-2030(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Europe Rare Disease Treatment Market, By End-User, 2017-2030(US$ Mn)
20.10.1. Overview
20.10.2. SRC Analysis
20.11. Europe Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030(US$ Mn)
20.11.1. Overview
20.11.2. SRC Analysis
20.12. Europe Rare Disease Treatment Market, by Country, 2017-2030 (US$ Mn)
20.12.1. Europe Rare Disease Treatment Market, by Country, 2022 Vs 2030 (in%)
20.12.2. UK
20.12.3. France
20.12.4. Germany
20.12.5. Italy
20.12.6. Spain
20.12.7. Benelux
20.12.8. Russia
20.12.9. Rest of Europe
21. Asia Pacific Rare Disease Treatment Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Asia Pacific Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Asia Pacific Rare Disease Treatment Market, By Gene Therapies, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Asia Pacific Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Asia Pacific Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Asia Pacific Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Asia Pacific Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Asia Pacific Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Asia Pacific Rare Disease Treatment Market, By Supportive Therapies, 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Asia Pacific Rare Disease Treatment Market, By End-User, 2017-2030(US$ Mn)
21.10.1. Overview
21.10.2. SRC Analysis
21.11. Asia Pacific Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030(US$ Mn)
21.11.1. Overview
21.11.2. SRC Analysis
21.12. Asia Pacific Rare Disease Treatment Market, by Country, 2017-2030 (US$ Mn)
21.12.1. Asia Pacific Rare Disease Treatment Market, by Country, 2022 Vs 2030 (in%)
21.12.2. China
21.12.3. Japan
21.12.4. India
21.12.5. South Korea
21.12.6. South East Asia
21.12.7. Rest of Asia Pacific
22. Latin America Rare Disease Treatment Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Latin America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Latin America Rare Disease Treatment Market, By Gene Therapies, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Latin America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Latin America Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Latin America Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Latin America Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Latin America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Latin America Rare Disease Treatment Market, By Supportive Therapies, 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Latin America Rare Disease Treatment Market, By End-User, 2017-2030(US$ Mn)
22.10.1. Overview
22.10.2. SRC Analysis
22.11. Latin America Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030(US$ Mn)
22.11.1. Overview
22.11.2. SRC Analysis
22.12. Latin America Rare Disease Treatment Market, by Country, 2017-2030 (US$ Mn)
22.12.1. Latin America Rare Disease Treatment Market, by Country, 2022 Vs 2030 (in%)
22.12.2. Brazil
22.12.3. Argentina
22.12.4. Rest of Latin America
23. Middle East Rare Disease Treatment Market Analysis
23.1. Overview
23.1.1. Market Dynamics for North America
23.1.1.1. Drivers
23.1.1.2. Restraints
23.1.1.3. Opportunities
23.1.1.4. Trends
23.2. Middle East Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030(US$ Mn)
23.2.1. Overview
23.2.2. SRC Analysis
23.3. Middle East Rare Disease Treatment Market, By Gene Therapies, 2017-2030(US$ Mn)
23.3.1. Overview
23.3.2. SRC Analysis
23.4. Middle East Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030(US$ Mn)
23.4.1. Overview
23.4.2. SRC Analysis
23.5. Middle East Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030(US$ Mn)
23.5.1. Overview
23.5.2. SRC Analysis
23.6. Middle East Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030(US$ Mn)
23.6.1. Overview
23.6.2. SRC Analysis
23.7. Middle East Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030(US$ Mn)
23.7.1. Overview
23.7.2. SRC Analysis
23.8. Middle East Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030(US$ Mn)
23.8.1. Overview
23.8.2. SRC Analysis
23.9. Middle East Rare Disease Treatment Market, By Supportive Therapies, 2017-2030(US$ Mn)
23.9.1. Overview
23.9.2. SRC Analysis
23.10. Middle East Rare Disease Treatment Market, By End-User, 2017-2030(US$ Mn)
23.10.1. Overview
23.10.2. SRC Analysis
23.11. Middle East Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030(US$ Mn)
23.11.1. Overview
23.11.2. SRC Analysis
23.12. Middle East Rare Disease Treatment Market, by Country, 2017-2030 (US$ Mn)
23.12.1. Middle East Rare Disease Treatment Market, by Country, 2022 Vs 2030 (in%)
23.12.2. UAE
23.12.3. Saudi Arabia
23.12.4. Rest of Middle East
24. Africa Rare Disease Treatment Market Analysis
24.1. Overview
24.1.1. Market Dynamics for North America
24.1.1.1. Drivers
24.1.1.2. Restraints
24.1.1.3. Opportunities
24.1.1.4. Trends
24.2. Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2030(US$ Mn)
24.2.1. Overview
24.2.2. SRC Analysis
24.3. Africa Rare Disease Treatment Market, By Gene Therapies, 2017-2030(US$ Mn)
24.3.1. Overview
24.3.2. SRC Analysis
24.4. Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2030(US$ Mn)
24.4.1. Overview
24.4.2. SRC Analysis
24.5. Africa Rare Disease Treatment Market, By Small Molecule Therapies, 2017-2030(US$ Mn)
24.5.1. Overview
24.5.2. SRC Analysis
24.6. Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2030(US$ Mn)
24.6.1. Overview
24.6.2. SRC Analysis
24.7. Africa Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2030(US$ Mn)
24.7.1. Overview
24.7.2. SRC Analysis
24.8. Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2030(US$ Mn)
24.8.1. Overview
24.8.2. SRC Analysis
24.9. Africa Rare Disease Treatment Market, By Supportive Therapies, 2017-2030(US$ Mn)
24.9.1. Overview
24.9.2. SRC Analysis
24.10. Africa Rare Disease Treatment Market, By End-User, 2017-2030(US$ Mn)
24.10.1. Overview
24.10.2. SRC Analysis
24.11. Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2030(US$ Mn)
24.11.1. Overview
24.11.2. SRC Analysis
24.12. Africa Rare Disease Treatment Market, by Country, 2017-2030 (US$ Mn)
24.12.1. Middle East Rare Disease Treatment Market, by Country, 2022 Vs 2030 (in%)
24.12.2. South Africa
24.12.3. Egypt
24.12.4. Rest of Africa
25. Company Profiles
25.1. F. Hoffmann-La Roche Ltd.
25.1.1. Company Overview
25.1.2. Types/Services Portfolio
25.1.3. Geographical Presence
25.1.4. SWOT Analysis
25.1.5. Financial Summary
25.1.5.1. Market Revenue and Net Profit (2019-2022)
25.1.5.2. Business Segment Revenue Analysis
25.1.5.3. Geographical Revenue Analysis
25.2. Pfizer, Inc.
25.3. PTC Therapeutics
25.4. AstraZeneca
25.5. Novartis AG
25.6. Novo Nordisk
25.7. Bayer AG
25.8. AbbVie Inc.
25.9. Merck & Co. Inc.
25.10. Bristol Myers Squibb.
26. Research Methodology
26.1. Research Methodology
26.2. For Lysosomal Storage Disorders – Secondary Research
26.3. For Lysosomal Storage DisordersI – Data Modelling
26.3.1. Company Share Analysis Model
26.3.2. Revenue Based Modelling
26.4. For Lysosomal Storage DisordersII – Primary Research
26.5. Research Limitations
26.5.1. Assumptions

List of Figures
FIG. 1 Global Rare Disease Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Rare Disease Treatment Market Segmentation
FIG. 4 Global Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2022 (US$ Mn)
FIG. 5 Global Rare Disease Treatment Market, By Gene Therapies, 2022 (US$ Mn)
FIG. 6 Global Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2022 (US$ Mn)
FIG. 7 Global Rare Disease Treatment Market, by Small Molecule Therapies, 2022 (US$ Mn)
FIG. 8 Global Rare Disease Treatment Market, By Stem Cell Therapies, 2022 (US$ Mn)
FIG. 9 Global Rare Disease Treatment Market, By Rare Cancer Therapies, 2022 (US$ Mn)
FIG. 10 Global Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2022 (US$ Mn)
FIG. 11 Global Rare Disease Treatment Market, By Supportive Therapies, 2022 (US$ Mn)
FIG. 12 Global Rare Disease Treatment Market, by End-User, 2022 (US$ Mn)
FIG. 13 Global Rare Disease Treatment Market, By Collaborations and Partnerships, 2022 (US$ Mn)
FIG. 14 Global Rare Disease Treatment Market, by Geography, 2022 (US$ Mn)
FIG. 15 Attractive Investment Proposition, By Pharmaceuticals and Biologics, 2022
FIG. 16 Attractive Investment Proposition, By Gene Therapies, 2022
FIG. 17 Attractive Investment Proposition, By Enzyme Replacement Therapies (ERT), 2022
FIG. 18 Attractive Investment Proposition, By Small Molecule Therapies, 2022
FIG. 19 Attractive Investment Proposition, By Stem Cell Therapies, 2022
FIG. 20 Attractive Investment Proposition, By Rare Cancer Therapies, 2022
FIG. 21 Attractive Investment Proposition, By Diagnostic and Monitoring Tools, 2022
FIG. 22 Attractive Investment Proposition, By Supportive Therapies, 2022
FIG. 23 Attractive Investment Proposition, By End-User, 2022
FIG. 24 Attractive Investment Proposition, By Collaborations and Partnerships, 2022
FIG. 25 Attractive Investment Proposition, by Geography, 2022
FIG. 26 Global Market Share Analysis of Key Rare Disease Treatment Market Manufacturers, 2022
FIG. 27 Global Market Positioning of Key Rare Disease Treatment Market Manufacturers, 2022
FIG. 28 Global Rare Disease Treatment Market Value Contribution, By Pharmaceuticals and Biologics, 2022 & 2030 (Value %)
FIG. 29 Global Rare Disease Treatment Market, by ORPHAN DRUGS, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Rare Disease Treatment Market, by Biological Therapies, Value, 2017-2030 (US$ Mn)
FIG. 31 Global Rare Disease Treatment Market Value Contribution, By Gene Therapies, 2022 & 2030 (Value %)
FIG. 32 Global Rare Disease Treatment Market, by Gene Replacement Therapies, Value, 2017-2030 (US$ Mn)
FIG. 33 Global Rare Disease Treatment Market, by Gene Editing Technologies, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Rare Disease Treatment Market Value Contribution, By Enzyme Replacement Therapies (ERT), 2022 & 2030 (Value %)
FIG. 35 Global Rare Disease Treatment Market, by For Lysosomal Storage Disorders, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Rare Disease Treatment Market Value Contribution, By Small Molecule Therapies, 2022 & 2030 (Value %)
FIG. 37 Global Rare Disease Treatment Market, by Chaperone Therapies, Value, 2017-2030 (US$ Mn)
FIG. 38 Global Rare Disease Treatment Market, by Modulators of Disease Pathways, Value, 2017-2030 (US$ Mn)
FIG. 39 Global Rare Disease Treatment Market Value Contribution, By Stem Cell Therapies, 2022 & 2030 (Value %)
FIG. 40 Global Rare Disease Treatment Market, by Hematopoietic Stem Cell Transplantation (HSCT), Value, 2017-2030 (US$ Mn)
FIG. 41 Global Rare Disease Treatment Market, by Mesenchymal Stem Cell Therapy, Value, 2017-2030 (US$ Mn)
FIG. 42 Global Rare Disease Treatment Market Value Contribution, By Rare Cancer Therapies, 2022 & 2030 (Value %)
FIG. 43 Global Rare Disease Treatment Market, by Targeted Therapies, Value, 2017-2030 (US$ Mn)
FIG. 44 Global Rare Disease Treatment Market, by Immunotherapies, Value, 2017-2030 (US$ Mn)
FIG. 45 Global Rare Disease Treatment Market Value Contribution, By Diagnostic and Monitoring Tools, 2022 & 2030 (Value %)
FIG. 46 Global Rare Disease Treatment Market, by Genetic Testing, Value, 2017-2030 (US$ Mn)
FIG. 47 Global Rare Disease Treatment Market, by Biomarker Testing, Value, 2017-2030 (US$ Mn)
FIG. 48 Global Rare Disease Treatment Market Value Contribution, By Supportive Therapies, 2022 & 2030 (Value %)
FIG. 49 Global Rare Disease Treatment Market, by Palliative Care, Value, 2017-2030 (US$ Mn)
FIG. 50 Global Rare Disease Treatment Market, by Symptomatic Treatments, Value, 2017-2030 (US$ Mn)
FIG. 51 Global Rare Disease Treatment Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 52 Global Rare Disease Treatment Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)
FIG. 53 Global Rare Disease Treatment Market, by Specialty Treatment Centers, Value, 2017-2030 (US$ Mn)
FIG. 54 Global Rare Disease Treatment Market, by Home Healthcare, Value, 2017-2030 (US$ Mn)
FIG. 55 Global Rare Disease Treatment Market Value Contribution, By Collaborations and Partnerships, 2022 & 2030 (Value %)
FIG. 56 Global Rare Disease Treatment Market, by Academic and Industry Collaborations, Value, 2017-2030 (US$ Mn)
FIG. 57 North America Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 58 U.S. Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 59 Canada Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 60 Mexico Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 61 Europe Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 62 Germany Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 63 France Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 64 U.K. Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 65 Italy Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 66 Spain Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 67 Benelux Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 68 Russia Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 69 Rest of Europe Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 70 Asia Pacific Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 71 China Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 72 Japan Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 73 India Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 74 South Korea Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 75 South-East Asia Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 76 Rest of Asia Pacific Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 77 Latin America Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 78 Brazil Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 79 Argentina Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 80 Rest of Latin America Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 81 Middle East Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 82 UAE Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 83 Saudi Arabia Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 84 Rest of Middle East Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 85 Africa Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 86 South Africa Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 87 Egypt Rare Disease Treatment Market, 2017-2030 (US$ Mn)
FIG. 88 Rest of Africa Rare Disease Treatment Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Rare Disease Treatment Market
TABLE 2 Global Rare Disease Treatment Market: Drivers Impact Analysis
TABLE 3 Global Rare Disease Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Rare Disease Treatment Market, by Competitive Benchmarking, 2022
TABLE 5 Global Rare Disease Treatment Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Rare Disease Treatment Market, by Key Strategies Analysis, 2022
TABLE 7 Global Rare Disease Treatment Market, by Orphan Drugs, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Rare Disease Treatment Market, by Orphan Drugs, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Rare Disease Treatment Market, by Biological Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Rare Disease Treatment Market, by Biological Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Rare Disease Treatment Market, by Gene Replacement Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Rare Disease Treatment Market, by Gene Replacement Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Rare Disease Treatment Market, by Gene Editing Technologies, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Rare Disease Treatment Market, by Gene Editing Technologies, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Rare Disease Treatment Market, by For Lysosomal Storage Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Rare Disease Treatment Market, by For Lysosomal Storage Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Rare Disease Treatment Market, by Chaperone Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Rare Disease Treatment Market, by Chaperone Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Rare Disease Treatment Market, by Modulators of Disease Pathways, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Rare Disease Treatment Market, by Modulators of Disease Pathways, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Rare Disease Treatment Market, by Hematopoietic Stem Cell Transplantation (HSCT), By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Rare Disease Treatment Market, by Hematopoietic Stem Cell Transplantation (HSCT), By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Rare Disease Treatment Market, by Mesenchymal Stem Cell Therapy), By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Rare Disease Treatment Market, by Mesenchymal Stem Cell Therapy), By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Rare Disease Treatment Market, by Targeted Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Rare Disease Treatment Market, by Targeted Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Rare Disease Treatment Market, by Immunotherapies, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Rare Disease Treatment Market, by Immunotherapies, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Rare Disease Treatment Market, by Genetic Testing, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Rare Disease Treatment Market, by Genetic Testing, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Rare Disease Treatment Market, by Biomarker Testing, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Rare Disease Treatment Market, by Biomarker Testing, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Rare Disease Treatment Market, by Palliative Care, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Rare Disease Treatment Market, by Palliative Care, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Rare Disease Treatment Market, by Symptomatic Treatments, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Rare Disease Treatment Market, by Symptomatic Treatments, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Rare Disease Treatment Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Rare Disease Treatment Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Rare Disease Treatment Market, by Specialty Treatment Centers, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Rare Disease Treatment Market, by Specialty Treatment Centers, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Rare Disease Treatment Market, by Home Healthcare, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Rare Disease Treatment Market, by Home Healthcare, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Rare Disease Treatment Market, by Academic and Industry Collaborations, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Rare Disease Treatment Market, by Academic and Industry Collaborations, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 46 Global Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 47 Global Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 48 Global Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 49 Global Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 50 Global Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 51 Global Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 52 Global Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 53 Global Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 54 Global Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 55 Global Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 56 Global Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 57 Global Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 58 Global Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 59 Global Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 60 Global Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 61 Global Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 62 Global Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 63 Global Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 64 Global Rare Disease Treatment Market, by Region, 2017-2022 (US$ Mn)
TABLE 65 Global Rare Disease Treatment Market, by Region, 2023-2030 (US$ Mn)
TABLE 66 North America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 67 North America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 68 North America Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 69 North America Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 70 North America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 71 North America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 72 North America Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 73 North America Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 74 North America Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 75 North America Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 76 North America Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 77 North America Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 78 North America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 79 North America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 80 North America Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 81 North America Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 82 North America Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 83 North America Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 84 North America Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 85 North America Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 86 North America Rare Disease Treatment Market, by Country, 2017-2022 (US$ Mn)
TABLE 87 North America Rare Disease Treatment Market, by Country, 2023-2030 (US$ Mn)
TABLE 88 United States Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 89 United States Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 90 United States Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 91 United States Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 92 United States Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 93 United States Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 94 United States Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 95 United States Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 96 United States Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 97 United States Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 98 United States Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 99 United States Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 100 United States Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 101 United States Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 102 United States Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 103 United States Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 104 United States Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 105 United States Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 106 United States Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 107 United States Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 108 Canada Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 109 Canada Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 110 Canada Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 111 Canada Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 112 Canada Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 113 Canada Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 114 Canada Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 115 Canada Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 116 Canada Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 117 Canada Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 118 Canada Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 119 Canada Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 120 Canada Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 121 Canada Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 122 Canada Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 123 Canada Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 124 Canada Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 125 Canada Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 126 Canada Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 127 Canada Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 128 Mexico Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 129 Mexico Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 130 Mexico Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 131 Mexico Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 132 Mexico Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 133 Mexico Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 134 Mexico Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 135 Mexico Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 136 Mexico Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 137 Mexico Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 138 Mexico Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 139 Mexico Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 140 Mexico Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 141 Mexico Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 142 Mexico Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 143 Mexico Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 144 Mexico Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 145 Mexico Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 146 Mexico Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 147 Mexico Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 148 Europe Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 149 Europe Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 150 Europe Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 151 Europe Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 152 Europe Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 153 Europe Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 154 Europe Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 155 Europe Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 156 Europe Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 157 Europe Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 158 Europe Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 159 Europe Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 160 Europe Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 161 Europe Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 162 Europe Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 163 Europe Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 164 Europe Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 165 Europe Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 166 Europe Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 167 Europe Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 168 Europe Rare Disease Treatment Market, by Country, 2017-2022 (US$ Mn)
TABLE 169 Europe Rare Disease Treatment Market, by Country, 2023-2030 (US$ Mn)
TABLE 170 Germany Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 171 Germany Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 172 Germany Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 173 Germany Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 174 Germany Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 175 Germany Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 176 Germany Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 177 Germany Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 178 Germany Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 179 Germany Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 180 Germany Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 181 Germany Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 182 Germany Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 183 Germany Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 184 Germany Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 185 Germany Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 186 Germany Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 187 Germany Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 188 Germany Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 189 Germany Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 190 France Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 191 France Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 192 France Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 193 France Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 194 France Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 195 France Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 196 France Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 197 France Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 198 France Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 199 France Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 200 France Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 201 France Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 202 France Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 203 France Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 204 France Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 205 France Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 206 France Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 207 France Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 208 France Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 209 France Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 210 United Kingdom Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 211 United Kingdom Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 212 United Kingdom Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 213 United Kingdom Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 214 United Kingdom Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 215 United Kingdom Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 216 United Kingdom Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 217 United Kingdom Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 218 United Kingdom Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 219 United Kingdom Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 220 United Kingdom Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 221 United Kingdom Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 222 United Kingdom Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 223 United Kingdom Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 224 United Kingdom Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 225 United Kingdom Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 226 United Kingdom Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 227 United Kingdom Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 228 United Kingdom Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 229 United Kingdom Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 230 Italy Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 231 Italy Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 232 Italy Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 233 Italy Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 234 Italy Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 235 Italy Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 236 Italy Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 237 Italy Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 238 Italy Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 239 Italy Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 240 Italy Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 241 Italy Rare Disease Treatment Market, By Rare Cancer Therapies, 2023-2030 (US$ Mn)
TABLE 242 Italy Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 243 Italy Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 244 Italy Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 245 Italy Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 246 Italy Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 247 Italy Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 248 Italy Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 249 Italy Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 250 Spain Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 251 Spain Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 252 Spain Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 253 Spain Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 254 Spain Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 255 Spain Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 256 Spain Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 257 Spain Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 258 Spain Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 259 Spain Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 260 Spain Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 261 Spain Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 262 Spain Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 263 Spain Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 264 Spain Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 265 Spain Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 266 Spain Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 267 Spain Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 268 Spain Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 269 Spain Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 270 Benelux Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 271 Benelux Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 272 Benelux Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 273 Benelux Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 274 Benelux Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 275 Benelux Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 276 Benelux Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 277 Benelux Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 278 Benelux Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 279 Benelux Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 280 Benelux Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 281 Benelux Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 282 Benelux Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 283 Benelux Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 284 Benelux Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 285 Benelux Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 286 Benelux Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 287 Benelux Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 288 Benelux Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 289 Benelux Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 290 Russia Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 291 Russia Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 292 Russia Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 293 Russia Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 294 Russia Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 295 Russia Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 296 Russia Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 297 Russia Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 298 Russia Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 299 Russia Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 300 Russia Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 301 Russia Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 302 Russia Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 303 Russia Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 304 Russia Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 305 Russia Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 306 Russia Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 307 Russia Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 308 Russia Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 309 Russia Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 310 Rest of Europe Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 311 Rest of Europe Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 312 Rest of Europe Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 313 Rest of Europe Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 314 Rest of Europe Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 315 Rest of Europe Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 316 Rest of Europe Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 317 Rest of Europe Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 318 Rest of Europe Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 319 Rest of Europe Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 320 Rest of Europe Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 321 Rest of Europe Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 322 Rest of Europe Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 323 Rest of Europe Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 324 Rest of Europe Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 325 Rest of Europe Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 326 Rest of Europe Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 327 Rest of Europe Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 328 Rest of Europe Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 329 Rest of Europe Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 330 Asia Pacific Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 331 Asia Pacific Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 332 Asia Pacific Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 333 Asia Pacific Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 334 Asia Pacific Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 335 Asia Pacific Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 336 Asia Pacific Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 337 Asia Pacific Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 338 Asia Pacific Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 339 Asia Pacific Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 340 Asia Pacific Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 341 Asia Pacific Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 342 Asia Pacific Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 343 Asia Pacific Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 344 Asia Pacific Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 345 Asia Pacific Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 346 Asia Pacific Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 347 Asia Pacific Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 348 Asia Pacific Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 349 Asia Pacific Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 350 China Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 351 China Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 352 China Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 353 China Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 354 China Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 355 China Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 356 China Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 357 China Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 358 China Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 359 China Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 360 China Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 361 China Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 362 China Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 363 China Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 364 China Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 365 China Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 366 China Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 367 China Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 368 China Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 369 China Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 370 Japan Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 371 Japan Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 372 Japan Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 373 Japan Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 374 Japan Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 375 Japan Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 376 Japan Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 377 Japan Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 378 Japan Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 379 Japan Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 380 Japan Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 381 Japan Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 382 Japan Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 383 Japan Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 384 Japan Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 385 Japan Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 386 Japan Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 387 Japan Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 388 Japan Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 389 Japan Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 390 India Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 391 India Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 392 India Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 393 India Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 394 India Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 395 India Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 396 India Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 397 India Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 398 India Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 399 India Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 400 India Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 401 India Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 402 India Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 403 India Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 404 India Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 405 India Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 406 India Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 407 India Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 408 India Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 409 India Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 410 South Korea Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 411 South Korea Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 412 South Korea Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 413 South Korea Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 414 South Korea Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 415 South Korea Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 416 South Korea Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 417 South Korea Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 418 South Korea Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 419 South Korea Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 420 South Korea Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 421 South Korea Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 422 South Korea Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 423 South Korea Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 424 South Korea Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 425 South Korea Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 426 South Korea Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 427 South Korea Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 428 South Korea Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 429 South Korea Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 430 South-East Asia Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 431 South-East Asia Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 432 South-East Asia Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 433 South-East Asia Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 434 South-East Asia Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 435 South-East Asia Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 436 South-East Asia Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 437 South-East Asia Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 438 South-East Asia Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 439 South-East Asia Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 440 South-East Asia Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 441 South-East Asia Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 442 South-East Asia Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 443 South-East Asia Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 444 South-East Asia Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 445 South-East Asia Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 446 South-East Asia Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 447 South-East Asia Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 448 South-East Asia Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 449 South-East Asia Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 450 Rest of Asia Pacific Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 451 Rest of Asia Pacific Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 452 Rest of Asia Pacific Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 453 Rest of Asia Pacific Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 454 Rest of Asia Pacific Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 455 Rest of Asia Pacific Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 456 Rest of Asia Pacific Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 457 Rest of Asia Pacific Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 458 Rest of Asia Pacific Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 459 Rest of Asia Pacific Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 460 Rest of Asia Pacific Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 461 Rest of Asia Pacific Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 462 Rest of Asia Pacific Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 463 Rest of Asia Pacific Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 464 Rest of Asia Pacific Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 465 Rest of Asia Pacific Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 466 Rest of Asia Pacific Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 467 Rest of Asia Pacific Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 468 Rest of Asia Pacific Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 469 Rest of Asia Pacific Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 470 Latin America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 471 Latin America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 472 Latin America Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 473 Latin America Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 474 Latin America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 475 Latin America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 476 Latin America Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 477 Latin America Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 478 Latin America Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 479 Latin America Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 480 Latin America Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 481 Latin America Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 482 Latin America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 483 Latin America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 484 Latin America Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 485 Latin America Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 486 Latin America Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 487 Latin America Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 488 Latin America Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 489 Latin America Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 490 Brazil Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 491 Brazil Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 492 Brazil Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 493 Brazil Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 494 Brazil Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 495 Brazil Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 496 Brazil Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 497 Brazil Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 498 Brazil Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 499 Brazil Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 500 Brazil Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 501 Brazil Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 502 Brazil Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 503 Brazil Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 504 Brazil Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 505 Brazil Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 506 Brazil Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 507 Brazil Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 508 Brazil Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 509 Brazil Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 510 Argentina Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 511 Argentina Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 512 Argentina Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 513 Argentina Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 514 Argentina Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 515 Argentina Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 516 Argentina Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 517 Argentina Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 518 Argentina Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 519 Argentina Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 520 Argentina Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 521 Argentina Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 522 Argentina Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 523 Argentina Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 524 Argentina Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 525 Argentina Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 526 Argentina Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 527 Argentina Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 528 Argentina Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 529 Argentina Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 530 Rest of Latin America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 531 Rest of Latin America Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 532 Rest of Latin America Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 533 Rest of Latin America Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 534 Rest of Latin America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 535 Rest of Latin America Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 536 Rest of Latin America Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 537 Rest of Latin America Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 538 Rest of Latin America Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 539 Rest of Latin America Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 540 Rest of Latin America Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 541 Rest of Latin America Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 542 Rest of Latin America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 543 Rest of Latin America Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 544 Rest of Latin America Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 545 Rest of Latin America Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 546 Rest of Latin America Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 547 Rest of Latin America Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 548 Rest of Latin America Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 549 Rest of Latin America Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 550 Middle East Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 551 Middle East Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 552 Middle East Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 553 Middle East Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 554 Middle East Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 555 Middle East Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 556 Middle East Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 557 Middle East Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 558 Middle East Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 559 Middle East Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 560 Middle East Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 561 Middle East Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 562 Middle East Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 563 Middle East Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 564 Middle East Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 565 Middle East Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 566 Middle East Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 567 Middle East Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 568 Middle East Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 569 Middle East Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 570 UAE Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 571 UAE Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 572 UAE Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 573 UAE Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 574 UAE Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 575 UAE Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 576 UAE Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 577 UAE Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 578 UAE Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 579 UAE Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 580 UAE Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 581 UAE Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 582 UAE Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 583 UAE Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 584 UAE Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 585 UAE Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 586 UAE Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 587 UAE Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 588 UAE Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 589 UAE Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 590 Saudi Arabia Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 591 Saudi Arabia Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 592 Saudi Arabia Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 593 Saudi Arabia Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 594 Saudi Arabia Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 595 Saudi Arabia Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 596 Saudi Arabia Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 597 Saudi Arabia Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 598 Saudi Arabia Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 599 Saudi Arabia Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 600 Saudi Arabia Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 601 Saudi Arabia Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 602 Saudi Arabia Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 603 Saudi Arabia Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 604 Saudi Arabia Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 605 Saudi Arabia Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 606 Saudi Arabia Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 607 Saudi Arabia Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 608 Saudi Arabia Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 609 Saudi Arabia Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 610 Rest of Middle East Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 611 Rest of Middle East Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 612 Rest of Middle East Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 613 Rest of Middle East Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 614 Rest of Middle East Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 615 Rest of Middle East Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 616 Rest of Middle East Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 617 Rest of Middle East Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 618 Rest of Middle East Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 619 Rest of Middle East Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 620 Rest of Middle East Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 621 Rest of Middle East Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 622 Rest of Middle East Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 623 Rest of Middle East Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 624 Rest of Middle East Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 625 Rest of Middle East Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 626 Rest of Middle East Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 627 Rest of Middle East Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 628 Rest of Middle East Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 629 Rest of Middle East Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 630 Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 631 Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 632 Africa Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 633 Africa Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 634 Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 635 Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 636 Africa Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 637 Africa Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 638 Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 639 Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 640 Africa Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 641 Africa Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 642 Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 643 Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 644 Africa Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 645 Africa Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 646 Africa Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 647 Africa Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 648 Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 649 Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 650 South Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 651 South Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 652 South Africa Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 653 South Africa Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 654 South Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 655 South Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 656 South Africa Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 657 South Africa Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 658 South Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 659 South Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 660 South Africa Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 661 South Africa Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 662 South Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 663 South Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 664 South Africa Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 665 South Africa Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 666 South Africa Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 667 South Africa Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 668 South Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 669 South Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 670 Egypt Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 671 Egypt Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 672 Egypt Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 673 Egypt Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 674 Egypt Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 675 Egypt Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 676 Egypt Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 677 Egypt Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 678 Egypt Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 679 Egypt Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 680 Egypt Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 681 Egypt Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 682 Egypt Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 683 Egypt Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 684 Egypt Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 685 Egypt Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 686 Egypt Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 687 Egypt Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 688 Egypt Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 689 Egypt Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)
TABLE 690 Rest of Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2017-2022 (US$ Mn)
TABLE 691 Rest of Africa Rare Disease Treatment Market, By Pharmaceuticals and Biologics, 2023-2030 (US$ Mn)
TABLE 692 Rest of Africa Rare Disease Treatment Market, By Gene Therapies, 2017-2022 (US$ Mn)
TABLE 693 Rest of Africa Rare Disease Treatment Market, By Gene Therapies, 2023-2030 (US$ Mn)
TABLE 694 Rest of Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2017-2022 (US$ Mn)
TABLE 695 Rest of Africa Rare Disease Treatment Market, By Enzyme Replacement Therapies (ERT), 2023-2030 (US$ Mn)
TABLE 696 Rest of Africa Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 697 Rest of Africa Rare Disease Treatment Market, By Small Molecule Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 698 Rest of Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2017-2022 (US$ Mn)
TABLE 699 Rest of Africa Rare Disease Treatment Market, By Stem Cell Therapies, 2023-2030 (US$ Mn)
TABLE 700 Rest of Africa Rare Disease Treatment Market, By Rare Cancer Therapies, 2017-2022 (US$ Mn)
TABLE 701 Rest of Africa Rare Disease Treatment Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 702 Rest of Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2017-2022 (US$ Mn)
TABLE 703 Rest of Africa Rare Disease Treatment Market, By Diagnostic and Monitoring Tools, 2023-2030 (US$ Mn)
TABLE 704 Rest of Africa Rare Disease Treatment Market, By Supportive Therapies, 2017-2022 (US$ Mn)
TABLE 705 Rest of Africa Rare Disease Treatment Market, By Supportive Therapies, 2023-2030 (US$ Mn)
TABLE 706 Rest of Africa Rare Disease Treatment Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 707 Rest of Africa Rare Disease Treatment Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 708 Rest of Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2017-2022 (US$ Mn)
TABLE 709 Rest of Africa Rare Disease Treatment Market, By Collaborations and Partnerships, 2023-2030 (US$ Mn)

What is the current Gene Therapies of the worldwide Rare Disease Treatment Market?

In 2022, the global Rare Disease Treatment Market is expected to be worth USD 192455.5 million.

What is the predicted growth rate of the Rare Disease Treatment Market between 2023 and 2030?

The Rare Disease Treatment Market is estimated to increase at a CAGR of 12.50% between 2023 and 2030, reaching USD 493799.3 Million in 2030.

Which segment has the most market share in terms of Pharmaceuticals and Biologics?

In 2022, Biological therapies segment is considered dominating in the rare disease treatment market

Which Stem Cell Therapies segment governs the market demand for Rare Disease Treatment?

Hematopoietic Stem Cell Transplantation (HSCT) is the market’s most important segment.

Who are the major players in the global Rare Disease Treatment Market?

The top players include F. Hoffmann-La Roche Ltd.; Pfizer, Inc.; PTC Therapeutics; AstraZeneca.

AI in Wound Care Market

Published:
Report ID: 40725

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

AI in Oncology Market

Published:
Report ID: 40668

Automated Liquid Handling Systems Market

Published:
Report ID: 40663

Non Infectious Macular Edema Treatment Market

Published:
Report ID: 7337

U.S. Medical Device Contract Manufacturing Market

Published:
Report ID: 40557

Endoscopes Market

Published:
Report ID: 40551

Animal Wound Care Market

Published:
Report ID: 40564

Adeno Associated Viral Vector Market

Published:
Report ID: 40601

AI Based Drug Discovery Market

Published:
Report ID: 40608

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN